FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.3  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely pregabalin 150 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metronidazole 7.5 milligram/1 gram conventional release vaginal gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely risperidone 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous sulfate 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 30 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely famotidine 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ranitidine bismuth citrate 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mebendazole 100 milligram/1 each conventional release chewable tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sodium phenylbutyrate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bromocriptine (as bromocriptine mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nateglinide 60 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely estramustine phosphate (as estramustine phosphate sodium) 140 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyclophosphamide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flucloxacillin (as flucloxacillin sodium) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely rofecoxib 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely somatropin(rbe) 5.3 milligram/1 cartridge powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amisulpride 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metolazone 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fosfestrol tetrasodium 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely irbesartan 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely retigabine 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cilazapril 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prochlorperazine maleate 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fludrocortisone acetate 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely saquinavir (as saquinavir mesilate) 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ascorbic acid 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydroquinone 40 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zaleplon 10 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely clonazepam 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely retigabine 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mitomycin 2 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely losartan potassium 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely clodronate disodium 400 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely acetylcysteine 600 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thiamine hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely voriconazole 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely etidronate disodium 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flutamide 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely dehydroepiandrosterone 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely etoricoxib 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefaclor (as cefaclor monohydrate) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely colchicine 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely aprepitant 125 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ethosuximide 50 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zopiclone 3.75 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely promethazine hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tropisetron 5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trandolapril 4 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mianserin hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely doxycycline 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lactulose 670 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely warfarin sodium 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pentosan polysulfate sodium 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cilostazol 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trimipramine (as trimipramine maleate) 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluvastatin 20 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely valsartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lorazepam 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fludarabine phosphate 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely atorvastatin 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely demeclocycline hydrochloride 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin (as erythromycin ethylsuccinate) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely eprosartan (as eprosartan mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lormetazepam 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amifostine 375 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lacosamide 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely methylprednisolone 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril maleate 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ramipril 5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 283 of 342 Next End

    This concept is not in any reference sets

    Back to Start